The required aldol product 17 was next oxidized with
DessꢀMartin periodinane to give the ketone 10 in 68%
yield (Scheme 7). The ketone 10 was then oxidized with
DMDO15 to give the acyloin 9 as a single diastereomer, the
structure of which was assigned by NMR, especially the
NOE between the methyl and the acyloin proton. The
acyloin 9 was treated with concentrated HCl in THF at
25°C followed bydehydration withthe Burgessreagent3 to
give the proposed structure of mycosporulone as a mixture
of the alcohol epimers 1 and 1a in 21% yield. The spectral
data of the mixture of 1 and 1a were not consistent with the
data reported for mycosporulone, strongly suggesting a
structural misassignment. We were able to access both
epimers 1 (OH trans to Me) and 1a (OH cis to Me) and can
conclude that neither has the required spectral data of
mycosporulone. It should be pointed out that the steps in
thesynthesisfromthe aldolproduct 17to the epimers 1 and
1a cannot epimerize the quaternary center; had that oc-
curred by some unknown route, one would have expected
to see four final products instead of two. Based on these
observations, we postulate that the quaternary center (C1)
is of the wrong configuration.
Scheme 8. Synthesis of 1 from 3 and Structural Reassignment
In summary, a total synthesis of the proposed structure
of mycosporulone 1 and its C2-epimer 1a has been com-
pleted. The synthetic material 1 does not correspond to the
reported data for mycosporulone, strongly suggesting that
there has been a structural misassignment. Based on the
current synthesis and the previously reported spectro-
scopic data, we propose the structural revision of mycos-
porulone to compound 29. While attempting to access 29
via oxidation of the known 6-epi-50-hydroxymycosporu-
lone 3, the previously synthesized mixture of 1 and 1a was
produced instead. Thus we have reason to believe that
6-epi-50-hydroxymycosporulone 3 has also been misas-
signed and now propose its structure to be that of com-
pound 30. Lastly, a retro-aldol/aldol reaction sequence
was observed, generating the aldol products 17and 18. The
retro-aldol reaction takes place to alleviate the syn-pentane-
like interactions found in the lithium alkoxide 27. Future
efforts will be focused on elaborating the aldol product 18
by an analogous synthesis to the revised structure of
mycosporulone 29.
Scheme 7. Completion of Synthesis of 1 and 1a
In an attempt to prove that the revised structure of
mycosporulone was indeed 29, we requested and received a
gift of the known natural product, 6-epi-50-hydroxymycos-
porulone 3. After screening several conditions (Scheme 8),
we found that oxidation with SeO2 gave a mixture of
epimers in 37% yield (59% brsm) that was spectroscopi-
cally consistent with the previously synthesized proposed
structure for mycosporulone 1. Consequently, we con-
cluded that 6-epi-50-hydroxymycosporulone 3 also has
the configuration in which the methyl group and the ester
of the lactone are cis to one another, leading us to believe
that it has likewise been misassigned. The revised structure
30 as drawn is consistent with the NOE data reported for
6-epi-50-hydroxymycosporulone 3.2c,16
Acknowledgment. We thank Professor William Fenical
(Scripps Oceanography) and the Compound Transfer
Program of Pfizer, Inc., Groton, CT for providing authen-
tic samples of 3. Dr. P. Liu and H. V. Pham of the Houk
Laboratories are gratefully acknowledged for assistance
with calculations. Dr. S. Khan is acknowledged for X-ray
crystallographic assistance. J.J.C. gratefully acknowledges
a UCLA Excellence in First Year Academics and Research
Award and an American Chemical Society Graduate
Research Symposium Award.
Supporting Information Available. Experimental pro-
cedures and proton and carbon NMR for all new com-
pounds. This material is free of charge via the Internet at
(15) Murray, R. W.; Singh, M. Org. Synth. 1997, 74, 91.
(16) (a) Fukami, A.; Taniguchi, Y.; Nakamura, T.; Rho, M.-C.;
Kawaguchi, K.; Hayashi, M.; Komiyama, K.; Omura, S. J. Antibiot.
1999, 52, 501–504. (b) Roll, D. M.; Tischler, M.; Williamson, R. T.;
Carter, G. T. J. Antibiot. 2002, 55, 520–523.
The authors declare no competing financial interest.
Org. Lett., Vol. 14, No. 18, 2012
4901